Beijing Tong Ren Tang Chinese Medicine Co (FRA:TQR) Total Equity: €479.5 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:TQR Beijing Tong Ren Tang Chinese Medicine Co Ltd FRA:TQR
72 GF Score
Price €0.73
GF Value €1.05
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Beijing Tong Ren Tang Chinese Medicine Co Total Equity?

Beijing Tong Ren Tang Chinese Medicine Co FRA:TQR -2.01% 72 Total Equity is €479.5 Mil as of Dec. 2025. GuruFocus rates FRA:TQR with a GF Score™ of 72/100 and a GF Value™ of €1.05 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Beijing Tong Ren Tang Chinese Medicine Co's total equity for the quarter that ended in Dec. 2025 was €479.5 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Beijing Tong Ren Tang Chinese Medicine Co Total Equity Historical Data

* Premium members only.

The historical data trend for Beijing Tong Ren Tang Chinese Medicine Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Tong Ren Tang Chinese Medicine Co Total Equity Chart

Beijing Tong Ren Tang Chinese Medicine Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 401.65 453.34 472.10 521.70 479.52

Beijing Tong Ren Tang Chinese Medicine Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 472.10 472.18 521.70 466.41 479.52
FRA:TQR
72GF Score
Beijing Tong Ren Tang Chinese Medicine Co Ltd FRA:TQR
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beijing Tong Ren Tang Chinese Medicine Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Beijing Tong Ren Tang Chinese Medicine Co's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=511.55-32.036
=479.5

Beijing Tong Ren Tang Chinese Medicine Co's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=511.55-32.036
=479.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €479.5 Mil mean?
Beijing Tong Ren Tang Chinese Medicine Co (FRA:TQR) has a Total Equity of €479.5 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Beijing Tong Ren Tang Chinese Medicine Co and its competitors.
Is Beijing Tong Ren Tang Chinese Medicine Co's Total Equity too high?
Beijing Tong Ren Tang Chinese Medicine Co's current Total Equity is €479.5 Mil. Overall, Beijing Tong Ren Tang Chinese Medicine Co has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Tong Ren Tang Chinese Medicine Co's Total Equity compare to ZTS and UTHR?
Beijing Tong Ren Tang Chinese Medicine Co's Total Equity of €479.5 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Beijing Tong Ren Tang Chinese Medicine Co and its competitors. Beijing Tong Ren Tang Chinese Medicine Co's current Total Equity is €479.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Tong Ren Tang Chinese Medicine Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Tong Ren Tang Chinese Medicine Co (FRA:TQR) is currently considered Significantly Undervalued. The stock's GF Value™ is €1.05, compared to a current price of €0.73 — trading 30.5% below its estimated fair value. The current Total Equity is €479.5 Mil. Beijing Tong Ren Tang Chinese Medicine Co's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Beijing Tong Ren Tang Chinese Medicine Co (FRA:TQR), the current Total Equity is €479.5 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beijing Tong Ren Tang Chinese Medicine Co (FRA:TQR) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Tong Ren Tang Chinese Medicine Co stock appears to be undervalued. The current stock price of €0.73 is trading 30.5% below its estimated GF Value™ of €1.05. GuruFocus considers Beijing Tong Ren Tang Chinese Medicine Co to be Significantly Undervalued.

Key valuation signals for FRA:TQR:

  • Total Equity: €479.5 Mil
  • GF Value™: €1.05 vs. price of €0.73 (30.5% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the FRA:TQR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beijing Tong Ren Tang Chinese Medicine Co Business Description

Other Exchanges 03613:Hong Kong
Address Convention Plaza, 1 Harbour Road, Room 1405-1409, Office Tower, Wanchai, Hong Kong, HKG
Beijing Tong Ren Tang Chinese Medicine Co Ltd is a pharmaceutical retailer that specializes in Chinese medicine operating in three segments; Hong Kong includes the sale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments through retail and wholesale of Chinese medicine products and healthcare products; Chinese Mainland (PRC, but excluding Hong Kong, Macao, and Taiwan) includes wholesale of healthcare products in Chinese Mainland and the sole distributor of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd; and Overseas includes retail and wholesale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments.
72GF Score

Get the complete analysis for FRA:TQR

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.73
Price
€1.05
GF Value